Cochrane Abstracts
Sodium channel blockers for neuroprotection in multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sodium Channel Blockers for Neuroprotection in Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Sodium_channel_blockers_for_neuroprotection_in_multiple_sclerosis. Accessed 07 November 2024.
Sodium channel blockers for neuroprotection in multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Sodium_channel_blockers_for_neuroprotection_in_multiple_sclerosis. Accessed November 7, 2024.
Sodium channel blockers for neuroprotection in multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Sodium_channel_blockers_for_neuroprotection_in_multiple_sclerosis
Sodium Channel Blockers for Neuroprotection in Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 November 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Sodium_channel_blockers_for_neuroprotection_in_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium channel blockers for neuroprotection in multiple sclerosis
ID - 432673
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432673/all/Sodium_channel_blockers_for_neuroprotection_in_multiple_sclerosis
DB - Evidence Central
DP - Unbound Medicine
ER -
